^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Datalai (cetuximab biosimilar)

    i
    Other names: A140, KL 140, KL-140
    Associations

    News

    Trials
    Company:
    Sichuan Kelun Pharma
    Drug class:
    EGFR antagonist
    Related drugs:
    Associations

    News

    Trials
    3years
    Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC (clinicaltrials.gov)
    P3, N=686, Recruiting, Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
    Clinical • New P3 trial
    |
    KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • NRAS (Neuroblastoma RAS viral oncogene homolog)
    |
    BRAF V600E • BRAF V600
    |
    Erbitux (cetuximab) • oxaliplatin • Datalai (cetuximab biosimilar)
    5years
    Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial (clinicaltrials.gov)
    P3, N=570, Recruiting, Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
    Clinical • New P3 trial
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF V600E • BRAF V600
    |
    oxaliplatin • Datalai (cetuximab biosimilar)